Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Receptor Modulators (S1PRM)
Clinical trial NCT05828901 · TERMINATED
Trial details
- NCT number
- NCT05828901
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-27
- Primary completion
- 2025-10-16
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.